Company news: Emyria; Cann Group; Creso Pharma; Cronos; MGC Pharma by Martin Lane April 14, 2022April 14, 2022 Emyria Emyria has begun dosing participants in a Phase 1 clinical trial assessing the safety and […]
Cronos Australia and CDA Health agree merger deal by Hannah Adler September 14, 2021September 16, 2021
